Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Organ Modelling
Pavone High Throughput Mechanical Screening Platform
3D tissue models are revolutionizing diagnostics, drug development, and regenerative medicine fields.
Chemical Biology
Getting PROTACs into the Clinic: The Challenges
Oxford Global’s protein degradation panel discussion brought together leading experts in the field to talk about bringing PROTACs to clinical trial endpoints.
Target Discovery
Examining Target Identification and Validation in Drug Discovery
Target identification and validation forms the backbone of efforts to discover new drugs. Our expert panel discussed challenges and solutions in this field to drive safety and efficacy.
Chemical Biology
Next-Generation Targeted Protein Degradation: Beyond the Usual E3 Ligases
During Discovery Week 2021, Ian Churcher (Chief Scientific Officer at Amphista Therapeutics Limited) gave a fascinating presentation on recent advancements and novel approaches in protein degradation. This article provides a condensed overview of the key topics covered.
Organ Modelling
Validating Cellesce’s Bioreactor Technology for the Expansion of Patient-derived Breast Cancer Organoids
Cellesce develops bioprocessing systems for the expansion of organoids in significant volumes in a way that minimises handling time and maximises reproducibility, with the long term goal of positioning organoid technology as a cost effective model for early-stage drug discovery.
Pharma Data
Merck KGaA on Training a Data-Capable Workforce
Dr Boris Adryan, Digital & Data Capability Building Lead at Merck Healthcare KGaA, teaches the company’s workforce the importance of data.
Pharma Data
Accelerating Global Access to New Medicines Through FAIR
This Commentary piece looks at the means by which the global approval process for new medicines can be sped up through the controlled use of FAIR data. Key areas of focus include the sharing of healthcare data to bring the patient voice within the clinical setting.
Pharma Data
Mobile Health and Covid-19: How Did Big Data Help To Avoid The Worst Of The Pandemic?
This Commentary article revisits the development and implementation of mobile health data, exploring how initiatives such as the NHS track and trace system helped to mitigate the worst of the impact of the Covid-19 pandemic. Here, we consider the applications of mHealth data for present and future pandemic situations.
Automation
Smart Labs: Productivity, Legacy Systems and Digital Fatigue
Key opinion leaders discuss the latest trends and challenges in laboratory automation and digitalization. Key insights include an explanation of Roche's 'Levers of Production' method, the challenges of legacy systems and the possibility of digitalization overload.
Molecular Drug Design
How AI Integration is Optimising Drug Development Pipelines
How are AI integration and the growing capabilities of machine learning impacting drug discovery and clinical trials?